Cargando…

Neoadjuvant Pseudomonas aeruginosa mannose-sensitive hemagglutinin (PA-MSHA) and chemotherapy versus placebo plus chemotherapy in patients with HER2-negative breast cancer: a randomized, controlled, double-blind trial

BACKGROUND: According to preclinical experiments, Pseudomonas aeruginosa mannose-sensitive hemagglutinin (PA-MSHA) exerts antiproliferative effects against breast cancer cells. It has been approved by the State Food and Drug Administration in China for complementary cancer treatment, and its safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Yue, Zuo, Hua, Zhou, Ying, Yu, Ke-Da, Liu, Guang-Yu, Di, Gen-Hong, Wu, Jiong, Liu, Zhe-Bin, Shao, Zhi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113104/ https://www.ncbi.nlm.nih.gov/pubmed/37082658 http://dx.doi.org/10.21037/atm-22-4093

Ejemplares similares

Topical Application of Pseudomonas aeruginosa-Mannose Sensitive Hemagglutinin (PA-MSHA) for Refractory Lymphatic Leakage Following Lymphadenectomy in Patients with Gynecological Malignancies
por: Zhou, Rong, et al.
Publicado: (2021)

Inhibition of autophagy enhances the cytotoxic effect of PA-MSHA in breast cancer
por: Xu, Wen-Huan, et al.
Publicado: (2014)

The MSHA Strain of Pseudomonas Aeruginosa Activated TLR Pathway and Enhanced HIV-1 DNA Vaccine Immunoreactivity
por: Hou, Jue, et al.
Publicado: (2012)

Phase II Study of Pseudomonas aeruginosa-Mannose-Sensitive Hemagglutinin in Combination with Capecitabine for Her-2–Negative Metastatic Breast Cancer Pretreated with Anthracycline and Taxane
por: Lv, Fangfang, et al.
Publicado: (2015)

PA-MSHA induces apoptosis and suppresses metastasis by tumor associated macrophages in bladder cancer cells
por: Liu, Jianjun, et al.
Publicado: (2017)

Pseudomonas aeruginosa mannose-sensitive hemagglutinin inhibits proliferation and invasion via the PTEN/AKT pathway in HeLa cells
por: Yin, Tie-qiu, et al.
Publicado: (2016)

PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy
por: Huang, Min, et al.
Publicado: (2022)

Ultrasound-guided percutaneous injection of Pseudomonas aeruginosa-mannose sensitive hemagglutinin for treatment of chyle fistula following neck dissection: Two case reports
por: Chen, Qiang, et al.
Publicado: (2020)

Regulatory effect of Pseudomonas aeruginosa mannose-sensitive hemagglutinin on inflammation and immune function in percutaneous nephrolithotomy patients with upper urinary tract calculi complicated with infection
por: Zhao, Yuan, et al.
Publicado: (2023)

Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling
por: Cheng, Xi, et al.
Publicado: (2016)

Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits proliferation and induces apoptosis in a caspase-dependent manner in human bladder cancer cell lines
por: ZHU, YI-PING, et al.
Publicado: (2013)

The Effective Regulation of Pro- and Anti-inflammatory Cytokines Induced by Combination of PA-MSHA and BPIFB1 in Initiation of Innate Immune Responses
por: Zhou, Weiqiang, et al.
Publicado: (2017)

PA‐MSHA inhibits the growth of doxorubicin‐resistant MCF‐7/ADR human breast cancer cells by downregulating Nrf2/p62
por: Wei, Yingze, et al.
Publicado: (2016)

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer
por: Palmieri, Carlo, et al.
Publicado: (2015)

Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2023)

Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study)
por: Hasegawa, Yoshie, et al.
Publicado: (2015)

Can trastuzumab emtansine be replaced by additional chemotherapy plus targeted therapy for HER2-overexpressing breast cancer patients with residual disease after neoadjuvant chemotherapy?
por: Wu, Juan, et al.
Publicado: (2019)

PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells
por: Zhao, Xin-min, et al.
Publicado: (2016)

Photodynamic antimicrobial chemotherapy in mice with Pseudomonas aeruginosa-infected wounds
por: Zhao, Zhan-Juan, et al.
Publicado: (2020)

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
por: Natoli, Clara, et al.
Publicado: (2013)

Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
por: Mizuno, Takaaki, et al.
Publicado: (2020)

Crystal structure of the flavoenzyme PA4991 from Pseudomonas aeruginosa
por: Jacewicz, Agata, et al.
Publicado: (2016)

PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
por: Tan, Hao, et al.
Publicado: (2016)

Strategies for improved rhamnolipid production by Pseudomonas aeruginosa PA1
por: Soares dos Santos, Alexandre, et al.
Publicado: (2016)

The Role of PaFicT in Pseudomonas aeruginosa Persister Cell Formation
por: Fogen, Dawson
Publicado: (2021)

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer
por: Li, Si, et al.
Publicado: (2018)

Association Between the HER2 Protein Expression Level and the Efficacy of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
por: Yan, Hui, et al.
Publicado: (2020)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Jiang, Ben‐Yuan, et al.
Publicado: (2021)

Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer
por: Zhou, Shuling, et al.
Publicado: (2022)

Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials
por: Cao, Li, et al.
Publicado: (2015)

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
por: Denkert, Carsten, et al.
Publicado: (2013)

The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study
por: He, Hongbo, et al.
Publicado: (2022)

Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab
por: Wang, Xinle, et al.
Publicado: (2019)

Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC
por: Zheng, Shuyue, et al.
Publicado: (2022)

Genome Sequences of Three Strains of the Pseudomonas aeruginosa PA7 Clade
por: Boukerb, Amine M., et al.
Publicado: (2015)

Ginger Extract Inhibits Biofilm Formation by Pseudomonas aeruginosa PA14
por: Kim, Han-Shin, et al.
Publicado: (2013)

Draft Genome Sequence of Pseudomonas aeruginosa Strain PA14-UM
por: Lee, Vincent T., et al.
Publicado: (2020)

Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma
por: Yu, Hong, et al.
Publicado: (2023)

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gml5trdeq205sa4fldeds3e1gi